Image Analysis
Proscia at USCAP: See the Full Potential of Digital Pathology and AI Join Proscia at Booth 213, right across from the coffee bar. Experience how Concentriq®, our industry-leading digital pathology platform, and AI-driven insights...
Indica Labs: Learn about the latest advancements in AI-powered pathology CRC Macrodissect AI and Breast HER2 AI Sneak Peek Date: 27 March 2025 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 15:00 – 16:00...
From Pathology News: Analyzing the genetic content of cancer is an important step for accurate prognostication and treatment of affected patients. Tumor genetic testing is becoming increasingly more commonplace as the number of...
SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial intelligence (AI)-enabled prognostic and...
Join Proscia for a look at the future of Life Science. What’s New, What’s Next at Proscia for Life Sciences March 20 11:00 AM — 12:00 PM EDT Register View the Full Series Revolutionary advancements in technology...
Aiforia obtained the In Vitro Diagnostic Regulation (IVDR) certification and successfully launches three new CE-IVD marked AI solutions for breast and prostate cancer diagnostics Aiforia Technologies Plc, Press Release, February 20, 2025 at...
